Use of artemisia annua residue extract in control of tobacco bacterial wilt

WO2026237208A1PCT designated stage Publication Date: 2026-11-19SOUTHWEST UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2025/115837
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-16
Filing Date
2025-08-20
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Artemisia annua residue generated during artemisinin production has not been effectively utilized, resulting in resource waste and environmental pollution. At the same time, existing agents have limited effectiveness in controlling tobacco bacterial wilt.

Method used

Artemisia annua residue was extracted with organic solvents to prepare an Artemisia annua residue extract microemulsion. The optimized process conditions were ethyl acetate ratio of 82%, material-to-liquid ratio of 1:8, and extraction time of 77 minutes. It contains a multi-component synergistic system. After being prepared into a 4% Artemisia annua residue microemulsion, it was diluted to 1400 times and 800 times for tobacco control.

Benefits of technology

It achieves a high level of control over tobacco bacterial wilt with an efficiency of over 60%, which is superior to conventional agents. It also achieves environmentally friendly resource utilization and tobacco safety, possessing environmental friendliness, economy, and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2025115837_19112026_PF_FP_ABST
    Figure CN2025115837_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of plant disease control, and relates to the use of an Artemisia annua residue extract in the control of tobacco bacterial wilt. Provided is the use of an Artemisia annua residue extract in the control of tobacco bacterial wilt. The Artemisia annua residue extract is obtained by means of extracting an Artemisia annua residue raw material with an organic solvent. The organic solvent is a mixed solution of ethyl acetate and petroleum ether. The Artemisia annua residue raw material is a waste residue obtained after artemisinin is extracted from Artemisia annua. After the Artemisia annua residue extract is prepared into a 4% Artemisia annua residue extract microemulsion, 1400-fold and 800-fold dilutions thereof achieve a control efficacy of 60 % or more against tobacco bacterial wilt, which is superior to that of a 500-fold dilution of the conventional agent 20% thiodiazole-copper suspension agent.
Need to check novelty before this filing date? Find Prior Art

Description

Application of Artemisia annua residue extract in the prevention and control of tobacco bacterial wilt Technical Field

[0001] This invention belongs to the field of plant disease control technology, and relates to the application of Artemisia annua residue extract in the control of tobacco bacterial wilt. Background Technology

[0002] Artemisia annua L., a plant in the Asteraceae family, is a traditional Chinese medicine. The *Shennong Bencao Jing* (Shennong's Classic of Materia Medica) records its effects in relieving summer heat, reducing fever, and treating malaria. Studies have shown that Artemisia annua contains terpenes, flavonoids, coumarins, and volatile oils, and is the main source plant for artemisinin extraction. In current artemisinin extraction processes, extracting high-purity artemisinin from Artemisia annua generates a large amount of residue. This residue is often treated as feed additives or waste, resulting in significant resource waste and environmental pollution. Summary of the Invention

[0003] Based on this, the technical problem to be solved by the present invention is to provide an application of Artemisia annua residue extract prepared from the residue remaining after extracting artemisinin in the prevention and control of tobacco bacterial wilt. After the Artemisia annua residue extract is made into a 4% Artemisia annua residue extract microemulsion, its 1400-fold and 800-fold dilutions have a control effect of more than 60% on tobacco bacterial wilt, which is better than the conventional agent 20% thiabendazole copper suspension at 500-fold dilution.

[0004] On the one hand, the present invention relates to the application of Artemisia annua residue extract in the prevention and control of tobacco bacterial wilt, wherein the Artemisia annua residue extract is obtained by extracting Artemisia annua residue raw material with an organic solvent;

[0005] The organic solvent is a mixture of ethyl acetate and petroleum ether;

[0006] The raw material for the Artemisia annua residue is the waste residue from which artemisinin has been extracted from Artemisia annua.

[0007] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the proportion of ethyl acetate in the organic solvent is 80-100% by mass percentage.

[0008] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the ratio of the Artemisia annua residue raw material to the organic solvent is 1:6 to 1:10, calculated in g:mL.

[0009] Furthermore, in the application of the Artemisia annua residue extract provided by this invention in the prevention and control of tobacco bacterial wilt, the extraction time is 60-80 minutes.

[0010] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the Artemisia annua residue raw material is extracted with the organic solvent and then concentrated by macroporous adsorption resin.

[0011] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the macroporous adsorption resin is an NKA-2 type macroporous adsorption resin.

[0012] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the Artemisia annua residue extract mainly comprises, by mass percentage, 5% scopolamine, 3% artemisinic acid, 3% isofracil, 3% eugenol and 2% deoxyartemisinin.

[0013] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the Artemisia annua residue extract is prepared as a microemulsion before application.

[0014] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the microemulsion, by mass percentage, consists of 1-10% of the Artemisia annua residue extract, 20-30% of solvent, 15-20% of emulsifier, 1-10% of anionic surfactant, and the balance being water.

[0015] Furthermore, in the application of the Artemisia annua residue extract provided by the present invention in the prevention and control of tobacco bacterial wilt, the ratio of acetone, ethyl acetate and ethanol in the solvent is 2~3:1~3:1~3 by mass.

[0016] The emulsifier is EL-20;

[0017] The anionic surfactant is 500# (calcium dodecylbenzenesulfonate).

[0018] Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects or advantages:

[0019] This invention develops a highly efficient technical solution for controlling tobacco bacterial wilt by utilizing the waste residue from artemisinin production. Although the content of scopolamine lactone in the extract of Artemisia annua residue is only 5%, it forms a multi-component synergistic system with artemisinic acid (3%), isoflavone (3%), eugenol (3%), and deoxyartemisinin (2%), overcoming the limitations of traditional methods relying on a single active ingredient. Field trials show that a 4% Artemisia annua residue microemulsion prepared using an optimized process (82% ethyl acetate, 1:8 material-to-liquid ratio, and 77 minutes extraction time), after dilution to 1400 times and 800 times, achieves a control effect of over 60% on tobacco bacterial wilt, significantly superior to the conventional agent thiabendazole (30.78%~52.26%). Furthermore, this technology achieves resource utilization of waste, reduces environmental pollution, and the formulation has no adverse effects on tobacco growth (safety factor of 4), combining environmental friendliness, economy, and safety, providing an innovative solution for green agriculture. Attached Figure Description

[0020] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0021] Figure 1 is a line graph showing the effect of the ethyl acetate ratio on the extraction rate of scopolamine lactone.

[0022] Figure 2 is a line graph showing the effect of the solid-liquid ratio on the extraction rate of scopolamine lactone.

[0023] Figure 3 is a line graph showing the effect of extraction time on the extraction rate of scopolamine lactone.

[0024] Figure 4 shows the response surface plot of the interaction effect. Detailed Implementation

[0025] The technical solution of the present invention will be described below with reference to embodiments. However, the present invention is not limited to the following embodiments. Unless otherwise specified, the experimental and detection methods described in each embodiment are conventional methods; the reagents and materials described are commercially available unless otherwise specified. Unless otherwise specified, all percentages in the following embodiments refer to mass percentages. Unless otherwise specified, all proportions in the following embodiments refer to mass ratios.

[0026] In the following examples, the raw material of Artemisia annua residue is the waste residue from Artemisia annua after artemisinin extraction, which is obtained by rinsing and drying the solvent.

[0027] Scopolamine standard (98%) was purchased from Nanjing Herbal Source Biotechnology Co., Ltd.; ethyl acetate (99.7%), anhydrous ethanol and acetone (99.7%) were purchased from Shanghai Yi'en Chemical Technology Co., Ltd.; EL-20, 500# and petroleum ether (99.8%) were purchased from Chongqing Jiyuan Chemical Co., Ltd.

[0028] Example 1

[0029] This embodiment provides the preparation and purification process of Artemisia annua residue extract.

[0030] Accurately weigh 10.0 g of Artemisia annua residue and place it in a 250 mL volumetric flask. Add the corresponding volume of a mixture of ethyl acetate and petroleum ether, weigh the total weight, and perform reflux extraction under different conditions, with the temperature controlled at 60 ℃. Filter the hot filtrate, make up the weight loss, and accurately transfer 5 mL of the filtrate into a vial. After the solvent evaporates to dryness, dilute to 5 mL with methanol, filter through a 0.22 μm filter membrane, and perform liquid chromatography. Substitute the obtained peak area into the regression equation to obtain the concentration of the sample solution. After conversion, the extraction rate of hyoscyamine butylbromide in the sample can be calculated.

[0031] Using the extraction rate of scopolamine lactone as an indicator, this study investigated the effects of different ethyl acetate ratios, different solid-liquid ratios, and different extraction times on the extraction rate of scopolamine lactone. The single-factor settings are shown in Table 1. The three variables initially set were 50% ethyl acetate, a solid-liquid ratio of 1:10, and an extraction time of 60 min. The sample weight for each sample was 10.0 g.

[0032] Table 1 Single-factor experiments

[0033]

[0034] Using the ratio of ethyl acetate to petroleum ether as a variable, the effects of 10%, 20%, 50%, 80%, and 100% ethyl acetate on the extraction rate of scopolamine were compared when the material-to-liquid ratio was 1:10 and the extraction time was fixed at 60 min.

[0035] Using the solid-liquid ratio as a variable, the effects of solid-liquid ratios of 1:6, 1:8, 1:10, 1:12, and 1:14 on the extraction rate of scopolamine lactone were compared when the ethyl acetate ratio was 50% and the extraction time was fixed at 60 min.

[0036] With extraction temperature as a variable, the effects of extraction time of 40 min, 50 min, 60 min, 70 min, and 80 min on the extraction rate of scopolamine were compared when the ethyl acetate ratio was 50% and the solid-liquid ratio was fixed at 1:10.

[0037] Based on the optimal values ​​of each factor screened by single-factor experiments, a three-factor, three-level Box-Behnken experiment was designed using Design Expert 13 software for the ethyl acetate ratio (A), solid-liquid ratio (B), and extraction time (C) (as shown in Table 2). The optimal process conditions for scopolamine extraction were determined with the scopolamine extraction rate (Y) as the response index.

[0038] Table 2. Response Surface Experiment Factors and Levels

[0039]

[0040] As shown in Figure 1, the extraction rate of scopolamine lactone continuously increases with the increase of the proportion of ethyl acetate, reaching a peak at 80% ethyl acetate. This is because the solubility of scopolamine lactone in the sample is better with increasing ethyl acetate concentration. However, when the proportion is further increased to 100% ethyl acetate, the extraction rate of scopolamine lactone shows a downward trend. This may be because with the increase of ethyl acetate concentration, more fat-soluble substances are extracted, affecting the extraction of scopolamine lactone and thus reducing the extraction rate. Therefore, 80% ethyl acetate was selected as the optimal extraction solvent, with an extraction rate of 0.096%. Thus, 50%, 80%, and 100% ethyl acetate were selected as factors in the design of the response surface methodology.

[0041] As shown in Figure 2, the extraction yield of scopolamine was highest and the extraction effect was best when the solid-liquid ratio increased from 1:6 to 1:8. However, as the solid-liquid ratio continued to increase, the extraction rate showed a downward trend. Once the solvent volume reached a certain value, scopolamine was completely extracted. Continuing to increase the solvent volume would not only reduce the concentration of scopolamine in the unit extract but also waste resources. Therefore, solid-liquid ratios of 1:6, 1:8, and 1:10 were selected as factors in designing the response surface methodology.

[0042] As shown in Figure 3, the extraction rate of scopolamine lactone increased continuously with the increase of extraction time, reaching a maximum of 0.092% at 70 min. However, the extraction rate of scopolamine lactone decreased as the extraction time continued to increase. Therefore, 70 min was selected as the optimal extraction time, and 60 min, 70 min, and 80 min were selected as factors in the design of the response surface methodology.

[0043] The results of the response surface methodology are shown in Table 3. The effects of the independent variables—ethyl acetate ratio (A), solid-liquid ratio (B), and extraction time (C)—on the extraction rate (Y) of scopolamine lactone were fitted using Design Expert 13 software, and the following multiple regression equation was obtained:

[0044] Y=0.0923-0.0001A-0.0003B+0.0016C-0.0077AB+0.0070AC+0.0072BC-0.0079A 2 -0.0127B 2 -0.0029C 2

[0045] Table 3 Response Surface Experimental Design and Results

[0046]

[0047] Table 4 shows that the P-value of the regression model is 0.0123 (P < 0.05), therefore the model is significant. The P-value for the lack-of-fit term is 0.9471 (P > 0.05), indicating that the lack-of-fit term is not significant. This demonstrates that the model has high reliability, good fit, and can predict the optimal extraction process effectively. (Quadratic term A) 2 B 2 The interaction terms AB, AC, and BC showed significant effects on the extraction of scopolamine (P < 0.05), as did the linear terms A, B, and C, and the quadratic term C. 2 The extraction effect on scopolamine lactone was not significant (P>0.05). The influence of each factor was in the following order: C (extraction time) > B (solid-liquid ratio) > A (ethyl acetate ratio).

[0048] Table 4 Analysis of Variance

[0049]

[0050] As shown in Figure 4, the surface plots of each interaction response all open downwards and have a maximum point. The center of the minimum ellipse in the contour plot is located within the range of the selected experimental factors, indicating that the extraction rate of scopolamine lactone has a maximum value within the range of each factor setting. From the interaction response surfaces of each factor, it can be seen that the AB (ethyl acetate ratio and solid-liquid ratio) response surface has the steepest slope, indicating that the interaction between the ethyl acetate ratio and the solid-liquid ratio has the most significant impact on the extraction rate of scopolamine lactone. The extraction rate of scopolamine lactone peaks near 80% ethyl acetate and around a solid-liquid ratio of 1:8. The steepness of the BC (solid-liquid ratio and extraction time) response surface is less than that of AB, indicating that the interaction between the solid-liquid ratio and extraction time has a secondary impact on the extraction rate of scopolamine lactone. The extraction rate of scopolamine lactone peaks between a solid-liquid ratio of 1:8 and an extraction time of 70-80 min. Response surface methodology analysis revealed that the significance of the interaction effects of various factors on the extraction rate of scopolamine was in the order AB > BC > AC. The results of the surface methodology analysis were consistent with the significance analysis results of the regression model.

[0051] Using Design Expert 13 software to fit the regression equation model, the optimal extraction conditions for scopolamine lactone were determined to be: ethyl acetate ratio 81.525%, solid-liquid ratio 1:8.247, and extraction time 77.464 min. Considering practical feasibility, the ethyl acetate ratio was adjusted to 82%, and the solid-liquid ratio was adjusted to 1:8 (g·mL⁻¹). -1 The extraction time was adjusted to 77 min, and three repeated experiments were conducted for verification. The results showed that the extraction rate of scopolamine lactone was (0.091±0.0021)%, which was consistent with the expectations.

[0052] As shown in Table 5, the static adsorption capacity of 12 different types of macroporous adsorption resins was evaluated. The NKA-2 type macroporous adsorption resin was selected as having the strongest adsorption capacity for scopolamine, at 92.3%. Subsequently, the purification process of scopolamine was studied using the NKA-2 type macroporous resin. Through enrichment with macroporous adsorption resin, the purity of scopolamine could be increased from 1% to 5%, yielding an extract of Artemisia annua residue containing 5% scopolamine.

[0053] Table 5. Static adsorption capacity of different types of macroporous adsorption resins for scopolamine lactone

[0054]

[0055] Table 6. Main components of Artemisia annua residue extract

[0056]

[0057] The above-mentioned Artemisia annua residue extract prepared in this embodiment mainly includes 5% scopolamine, 3% artemisinic acid, 3% isofracil, 3% eugenol and 2% deoxyartemisinin.

[0058] Example 2

[0059] This embodiment provides the preparation of an artemisia annua residue microemulsion.

[0060] The solubility of Artemisia annua residue extract in different solvents was determined. It can be seen that the extract has the best solubility in acetone, and relatively high solubility in ethyl acetate, N,N-dimethylformamide and ethanol. Its solubility and cold storage stability in other solvents are poor.

[0061] Considering cost factors and in order to reduce the use of restrictive organic solvents, acetone, ethyl acetate and ethanol were selected for combination, and 42 solvent combinations were screened.

[0062] Based on the results in Table 7, and taking into account factors such as solubility, cost, and toxicity, the final solvent combination selected was acetone: ethyl acetate: ethanol in a ratio of 3:1:1 (total solvent content of 25%), for further screening of emulsifiers.

[0063] Table 7 Solvent combinations with good solubility for Artemisia annua residue extract

[0064]

[0065]

[0066]

[0067] Nonionic surfactants were screened under the above solvent ratios. The stability of the formulation, cold storage, hot storage, and dilution were evaluated. As shown in Table 8, EL-20 meets the relevant requirements. Therefore, EL-20 was selected as the emulsifier for the Artemisia annua residue extract microemulsion.

[0068] Table 8 Emulsifier Screening Results

[0069]

[0070] The selected emulsifier EL-20 was set into six content gradients. After adding the emulsifier to the solvent formulation determined above, deionized water was used to make up to 100%. As shown in Table 9, with the increase of emulsifier content, the appearance, low-temperature stability, thermal storage stability, and dilution stability of the microemulsion gradually improved. When the EL-20 content was 15%, the formulation basically met the relevant standards. Considering factors such as cost and environmental impact, the final determined content of emulsifier EL-20 in the Artemisia annua residue extract microemulsion was 15%.

[0071] Table 9 Results of Emulsifier Content Determination

[0072]

[0073] Based on the above series of experimental results, the formulation composition of the Artemisia annua residue extract microemulsion was finally determined, as shown in Table 10 below.

[0074] Table 10 Microemulsion Formulation Composition

[0075]

[0076] Example 3

[0077] This embodiment provides the impact of Artemisia annua residue microemulsion on tobacco safety.

[0078] Experimental Design and Survey: The safety test for each tobacco variety included four treatments: 800x, 1400x, and 2000x dilutions of Artemisia annua residue extract microemulsion, and a water control. Each plot was approximately 18 m². 2 Application method: The experiment involved two applications of pesticide. The first application was made after the tobacco plants had three leaves and one bud stage following transplanting, with a second application every 7-10 days. The amount of pesticide solution sprayed per plot each time was 1.36 L. Survey method: The plant height of each treatment was measured before the first application and 21 days after the last application. From the first application onwards, daily visual assessments were conducted to evaluate the presence of pesticide damage symptoms such as discoloration, necrosis, wilting, and deformity in the tobacco plants.

[0079] Results statistics: The safety of Artemisia annua residue extract microemulsion to tobacco is described by the following formula.

[0080]

[0081]

[0082]

[0083] The results of the investigation on the direct effects of the tested Artemisia annua residue extract microemulsion on the growth of three tobacco varieties are shown in Table 11. Within 21 days after treatment with 800, 1400 and 2000 times dilution of Artemisia annua residue extract microemulsion, no phytotoxic symptoms such as discoloration, necrosis, deformity or wilting were observed in the leaves of the three tobacco varieties.

[0084] The effects of the tested agent, Artemisia annua residue extract microemulsion, on tobacco growth and development are shown in Table 12. Table 12 shows that after treatment with 800, 1400, and 2000 times dilution of Artemisia annua residue extract microemulsion, there was no significant difference in plant height compared to the water control for the three tobacco varieties, and the growth rate inhibition rate was less than 10% for all three varieties, indicating that the tested agent is safe for tobacco growth.

[0085] In conclusion, the microemulsion treatment with Artemisia annua residue extract had no adverse effects on the growth of the three tobacco varieties, with a safety factor of 4.

[0086] Table 11 Effects of Artemisia annua residue extract microemulsion on tobacco safety

[0087]

[0088] Table 12 Effects of Artemisia annua residue extract microemulsion on tobacco growth

[0089]

[0090] Example 4

[0091] This embodiment provides the field control effect of Artemisia annua residue microemulsion on tobacco bacterial wilt.

[0092] Artemisia annua residue extract microemulsion was prepared and field efficacy trials were conducted. Trial locations: Zunyi, Guizhou; Weng'an, Guizhou; Qianjiang and Pengshui, Chongqing; Yibin, Sichuan.

[0093] Experimental treatments: A total of four treatments were administered, namely, 2000-fold dilution, 1400-fold dilution, 800-fold dilution of Artemisia annua residue microemulsion, and 500-fold dilution of 20% thiabendazole copper suspension. Each treatment was replicated three times, and each plot was approximately 30 m². 2 .

[0094] Application method: The experiment was conducted with two applications, one after the tobacco transplanting stage and the other during the vigorous growth stage. The amount of pesticide solution sprayed per plot each time was 2.25 L.

[0095] Survey Methods: The survey was conducted at the initial stage of tobacco bacterial wilt according to GB / 23222-2008 "Classification and Survey Methods for Tobacco Diseases and Pests". The classification standards are as follows:

[0096] Grade 0: The entire plant is disease-free;

[0097] Grade 1: Occasionally, there are chlorotic spots on the stem, or the leaves on the diseased side below 1 / 2 wither;

[0098] Grade 3: Black streaks appear on the stem, but do not exceed 1 / 2 of the stem height, or 1 / 2 to 2 / 3 of the leaves on the diseased side wither;

[0099] Grade 5: Black streaks on the stem extend beyond 1 / 2 of the stem height but do not reach the top of the stem, or more than 2 / 3 of the leaves on the affected side wither;

[0100] Level 7: Black streaks on the stem extend to the top of the stem, or all the leaves of the diseased plant wither.

[0101] Level 9: The diseased plants are basically dead.

[0102] The disease index and prevention efficacy are calculated using the following formula.

[0103]

[0104]

[0105] Table 13. Control efficacy of Artemisia annua residue extract microemulsion against tobacco bacterial wilt.

[0106]

[0107] As shown in Table 13, the 1400-fold and 800-fold dilutions of Artemisia annua residue extract microemulsions achieved a control effect of over 60% on tobacco bacterial wilt, which was superior to the control agent, 20% thiabendazole copper suspension at 500-fold dilution.

[0108] The embodiments described above are only some, not all, of the embodiments of the present invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the claimed invention, but merely to illustrate preferred embodiments. All other embodiments obtained by those skilled in the art through related deductions and substitutions based on the inventive concept, without inventive effort, are within the scope of protection of the present invention.

Claims

1. The application of Artemisia annua residue extract in the prevention and control of tobacco bacterial wilt, characterized in that, The Artemisia annua residue extract is obtained by extracting Artemisia annua residue raw material with an organic solvent; The organic solvent is a mixture of ethyl acetate and petroleum ether; The raw material for the Artemisia annua residue is the waste residue from which artemisinin has been extracted from Artemisia annua.

2. The application of the Artemisia annua residue extract according to claim 1 in the prevention and control of tobacco bacterial wilt, characterized in that, The organic solvent contains 80-100% ethyl acetate by mass percentage.

3. The application of the Artemisia annua residue extract according to claim 1 in the prevention and control of tobacco bacterial wilt, characterized in that, The ratio of the Artemisia annua residue raw material to the organic solvent is 1:6 to 1:10, expressed in g:mL.

4. The application of the Artemisia annua residue extract according to claim 1 in the prevention and control of tobacco bacterial wilt, characterized in that, The extraction time is 60-80 minutes.

5. The application of the Artemisia annua residue extract according to claim 1 in the prevention and control of tobacco bacterial wilt, characterized in that, Artemisia annua residue raw material is extracted with the organic solvent and then concentrated with macroporous adsorption resin.

6. The application of the Artemisia annua residue extract according to claim 5 in the prevention and control of tobacco bacterial wilt, characterized in that, The macroporous adsorption resin is NKA-2 type macroporous adsorption resin.

7. The application of the Artemisia annua residue extract according to claim 6 in the prevention and control of tobacco bacterial wilt, characterized in that, By weight percentage, the Artemisia annua residue extract mainly comprises 5% scopolamine, 3% artemisinic acid, 3% isofracil, 3% syringin and 2% deoxyartemisinin.

8. The application of the Artemisia annua residue extract according to claim 1 in the prevention and control of tobacco bacterial wilt, characterized in that, The Artemisia annua residue extract was prepared into a microemulsion and then applied.

9. The application of the Artemisia annua residue extract according to claim 8 in the prevention and control of tobacco bacterial wilt, characterized in that, The microemulsion, by mass percentage, consists of 1-10% of the Artemisia annua residue extract, 20-30% of solvent, 15-20% of emulsifier, 1-10% of anionic surfactant, and the balance being water.

10. The application of the Artemisia annua residue extract according to claim 9 in the prevention and control of tobacco bacterial wilt, characterized in that, The ratio of acetone, ethyl acetate and ethanol in the solvent is 2~3:1~3:1~3 by mass. The emulsifier is EL-20; The anionic surfactant is 500#.